CSIMarket
 


Pro dex Inc   (PDEX)
Other Ticker:  
 
 

PDEX's Capital Expenditures Growth by Quarter and Year

Pro Dex Inc 's Capital Expenditures results by quarter and year




PDEX Capital Expenditures (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter June - 0.00 0.40 1.80
III Quarter March - 0.14 0.20 0.01
II Quarter December 0.63 0.51 1.07 6.41
I Quarter September 0.13 0.18 0.00 0.09
FY   0.76 0.83 1.67 8.31



PDEX Capital Expenditures second quarter 2024 Y/Y Growth Comment
Pro dex Inc reported Capital Expenditures improvement of 24.12% year on year in the second quarter 2024, to $ 0.63 millions, this is lower than Pro Dex Inc 's recent average Capital Expenditures surge of 185.41%.

Looking into second quarter 2024 results within Medical Equipment & Supplies industry 11 other companies have achieved higher Capital Expenditures growth. While Pro Dex Inc ' s Capital Expenditures rise of 24.12% ranks overall at the positon no. 326 in the second quarter 2024.




PDEX Capital Expenditures ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter June - - -77.78 % 1185.71 %
III Quarter March - -30 % 1900 % -90.91 %
II Quarter December 24.12 % -52.34 % -83.31 % 2365.38 %
I Quarter September -27.78 % - - 50 %
FY   - -50.3 % -79.9 % 1357.89 %

Financial Statements
Pro Dex Inc 's second quarter 2024 Capital Expenditures $ 0.63 millions PDEX's Income Statement
Pro Dex Inc 's second quarter 2023 Capital Expenditures $ 0.51 millions Quarterly PDEX's Income Statement
New: More PDEX's historic Capital Expenditures Growth >>


PDEX Capital Expenditures (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter June - - 100 % 17900 %
III Quarter March - -72.55 % -81.31 % -99.84 %
II Quarter December 386.92 % 183.33 % - 7022.22 %
I Quarter September - -55 % - -35.71 %
FY (Year on Year)   - -50.3 % -79.9 % 1357.89 %




Capital Expenditures second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #12
Healthcare Sector #26
Overall #326

Capital Expenditures Y/Y Growth Statistics
High Average Low
1370.09 % 185.41 % -83.78 %
(Jun 30 2021)   (Dec 31 2015)
Capital Expenditures second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #12
Healthcare Sector #26
Overall #326
Capital Expenditures Y/Y Growth Statistics
High Average Low
1370.09 % 185.41 % -83.78 %
(Jun 30 2021)   (Dec 31 2015)

Capital Expenditures by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Pro Dex Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
19844.44 % 782.02 % -100 %
(Jun 30 2021)  


PDEX's II. Quarter Q/Q Capital Expenditures Comment
Pro dex Inc achieved in the II. Quarter 2024 below company average Capital Expenditures doubling of 386.92% quarter on quarter, to $ 0.63 millions.

Even if the II. Quarter 2024 performance was below the average , this was still good sign, as the II. Quarter surge, eclipses the 183.33% rise in the II. Quarter 2023

Within Medical Equipment & Supplies industry only one company achieved higher sequential Capital Expenditures growth. While Pro Dex Inc 's Capital Expenditures growth quarter on quarter, overall rank is 18.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #2
Healthcare Sector #3
Overall #18
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #2
Healthcare Sector #3
Overall #18
Capital Expenditures Q/Q Growth Statistics
High Average Low
19844.44 % 782.02 % -100 %
(Jun 30 2021)  


PDEX's II. Quarter Q/Q Capital Expenditures Comment
Pro dex Inc achieved in the II. Quarter 2024 below company average Capital Expenditures doubling of 386.92% quarter on quarter, to $ 0.63 millions.

II. Quarter 2024 results appear to be paradoxical, although lower than the average rise of 782.02 %, yet it demonstrates real acceleration relative to the 183.33% in the II. Quarter 2023 Theo  Robinson, Medical Equipment & Supplies industry researcher mentioned.

Within Medical Equipment & Supplies industry only one company achieved higher sequential Capital Expenditures growth. While Pro Dex Inc 's Capital Expenditures growth quarter on quarter, overall rank is 18.


Pro Dex Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 1.22 $ 1.29
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - -4.9 % -30.45 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 326 # 1933 # 1991 # 1669 # 1627




Cumulative Capital Expenditures growth Comment
Pro Dex Inc realized trailing twelve months Capital Expenditures of $ 0 millions, in the Dec 31 2023, compare to Capital Expenditures of $ 1 millions a year ago.

Pro dex Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
1370.09 %
185.41 %
-83.78 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 26
S&P 500 # 326
Cumulative Capital Expenditures growth Comment
Pro Dex Inc realized trailing twelve months Capital Expenditures of $ 0 millions, in the Dec 31 2023, compare to Capital Expenditures of $ 1 millions a year ago.

Pro dex Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
1370.09 %
185.41 %
-83.78 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 26
S&P 500 # 326




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
PDEX's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for PDEX's Competitors
Capital Expenditures Growth for Pro Dex Inc 's Suppliers
Capital Expenditures Growth for PDEX's Customers

You may also want to know
PDEX's Annual Growth Rates PDEX's Profitability Ratios PDEX's Asset Turnover Ratio PDEX's Dividend Growth
PDEX's Roe PDEX's Valuation Ratios PDEX's Financial Strength Ratios PDEX's Dividend Payout Ratio
PDEX's Roa PDEX's Inventory Turnover Ratio PDEX's Growth Rates PDEX's Dividend Comparisons



Companies with similar Capital Expenditures doubling for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Dec 31 2023
Laboratory Corporation Of America Holdings41.82%$ 41.815 millions
Livanova Plc41.44%$ 41.439 millions
Revance Therapeutics Inc 38.12%$ 38.121 millions
Entrada Therapeutics Inc 37.85%$ 37.853 millions
Beigene ltd 37.54%$ 37.536 millions
Inari Medical Inc 34.98%$ 34.983 millions
Henry Schein Inc34.48%$ 34.483 millions
Healthcare Services Group Inc 34.18%$ 34.176 millions
Veracyte inc 33.39%$ 33.387 millions
Haemonetics Corporation32.32%$ 32.324 millions
Steris Plc29.53%$ 29.533 millions
Organon and Co 28.57%$ 28.571 millions
Brookdale Senior Living Inc 26.22%$ 26.219 millions
Boston Scientific Corporation25.94%$ 25.943 millions
Lifemd Inc 25.16%$ 25.162 millions
Globus Medical Inc 24.76%$ 24.760 millions
Astrazeneca Plc24.75%$ 24.748 millions
Pro dex Inc 24.36%$ 24.361 millions
Abbott Laboratories23.77%$ 23.770 millions
Cel sci Corporation21.05%$ 21.054 millions
Avanos Medical Inc 20.41%$ 20.408 millions
National Vision Holdings Inc 19.62%$ 19.623 millions
Gilead Sciences Inc 18.78%$ 18.785 millions
Butterfly Network inc 18.38%$ 18.379 millions
Protalix Biotherapeutics inc 17.37%$ 17.371 millions
Integer Holdings Corporation17.15%$ 17.145 millions
Abcellera Biologics Inc 17.04%$ 17.040 millions
Iovance Biotherapeutics Inc 16.78%$ 16.777 millions
Zoetis Inc 15.79%$ 15.789 millions
West Pharmaceutical Services Inc 14.54%$ 14.542 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com